Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation

Maansi Joshi*, John Taper, Cecily Forsyth, Philip Rowlings, Philip Campbell, Philip Crispin, Michael Harvey, Craig Underhill, Angela Bayley, Karen Byth, Gillian Huang, Mark Hertzberg

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    7 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation'. Together they form a unique fingerprint.

    Medicine and Dentistry